ORIGINAL RESEARCH article
Front. Psychiatry
Sec. Public Mental Health
Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1615271
This article is part of the Research TopicMental Health Challenges in Long-term Pharmacotherapy for Patients with Chronic DiseasesView all 8 articles
Psychological Capital Mediates the Relationship Between Medication Adherence and Cancer-Related Fatigue in Breast Cancer Patients Undergoing Long-term Treatment
Provisionally accepted
- 1Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China
- 2Department of Nursing, Third Xiangya Hospital, Central South University, Changsha, Hunan Province, China
- 3Changsha Medical University, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Breast cancer is one of the most prevalent malignant tumors among women worldwide. Although long-term pharmacological treatment has substantially improved survival rates, it is often accompanied by psychological burdens, including cancer-related fatigue (CRF) and diminished adherence to therapy. CRF is a pervasive and debilitating symptom that adversely affects physical functioning and emotional well-being. Psychological capital (PsyCap), a construct encompassing self-efficacy, hope, optimism, and resilience, has been shown to enhance treatment engagement and promote mental health. However, its role as a potential psychological mediator between medication adherence and CRF is yet to be thoroughly investigated.Objective: To investigate the mediating role of PsyCap in the relationship between medication adherence and CRF in patients with breast cancer undergoing long-term treatment.Methods: A total of 100 breast cancer patients admitted between June 2022 and June 2024 were recruited using convenience sampling. Data from 90 valid responses were analyzed. Participants completed the PsyCap Questionnaire (PCQ-24), Self-Reported Medication Adherence Rating Scale (SR-MARS), and CRF Scale (CFS). Pearson’s correlation analysis was used to assess associations among variables. A mediation analysis was conducted using the bootstrap method with 5,000 resamples.Results: The mean scores for PsyCap, medication adherence, and CRF were 86.65 ± 8.37, 5.36 ± 1.12, and 36.77 ± 5.98, respectively. PsyCap was positively correlated with medication adherence (r = 0.994, p < 0.05) and negatively correlated with CRF (r = –0.992, p < 0.05). Medication adherence was also negatively correlated with CRF (r = –0.994, p < 0.05). Mediation analysis confirmed that PsyCap significantly mediated the relationship between medication adherence and CRF (indirect effect = 0.357, 95% CI did not include zero), accounting for 55.68% of the total effect.Conclusion: PsyCap partially mediated the association between medication adherence and CRF. Interventions aimed at enhancing PsyCap may improve adherence and reduce CRF in breast cancer patients receiving long-term pharmacotherapy.
Keywords: breast cancer, Psychological Capital, Medication Adherence, Cancer-related fatigue, Mediating effect, Long-term pharmacotherapy, Positive Psychology, Mental Health
Received: 21 Apr 2025; Accepted: 12 Jun 2025.
Copyright: © 2025 Yan and Chu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yane Chu, Changsha Medical University, Changsha, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.